Why Better Member Identification Matters for Health Plan Cost Predictability
One of the hardest problems to solve for health plan finance and actuarial leaders is not simply high cost. It is unstable cost.
A relatively small group of members living with serious illness can account for a disproportionate share of spending, and their costs often rise in irregular, difficult-to-forecast ways. A preventable hospitalization, a rapid decline after discharge, an unmanaged symptom crisis, or a late-stage ICU admission can quickly turn a high-need member into a high-volatility one. That makes serious-illness care not just a clinical challenge, but a financial predictability challenge.
Reducing cost is important, but making serious-illness spend more predictable is critical. The Carelon Palliative Care model is built around stabilizing high-need members before conditions escalate into higher-cost events such as ED visits, hospitalizations, and ICU stays.
That framing matters. For finance leaders and teams, the goal is not only to lower total cost of care. It is to improve confidence in how that cost behaves.
Why targeted serious-illness identification improves cost predictability
One reason serious-illness spending can be so difficult to manage is that many interventions are too broad. They spread resources across large populations, even though the greatest financial pressure is often concentrated in a much narrower patient segment.
Carelon's approach is different. The model is designed to focus on the highest-risk, highest-cost members rather than apply a broad population strategy. Carelon uses a predictive modeling approach that analyzes 200+ clinical, utilization, and behavioral data points and focuses on the members most likely to deteriorate or generate future utilization, roughly the top 1% to 1.5% of the population.
That targeted approach is important because predictability improves when intervention is concentrated where volatility is most likely to occur. Instead of waiting for cost instability to show up in claims, plans can identify the members most likely to drive it and act earlier.
Why precision matters more than scale for high-cost members
For finance and actuarial teams, scale can be tempting. But in serious-illness care, precision may matter more.
The question is not how many members can be reached. It is whether the right members can be identified before their care becomes more acute, fragmented, and expensive. A small number of members with advanced cancer, heart failure, COPD, renal disease, dementia, or other serious conditions may have an outsized influence on claims volatility. Missing them early can mean missing the window to prevent escalation.
Carelon connects that identification process directly to financial stability. The model helps make serious-illness spend more predictable by stabilizing high-need members before conditions escalate, and it ties that predictability to a set of specific interventions: early identification of high-risk members, proactive symptom management, 24/7 clinical access, advance care planning, and timely transitions when clinically appropriate.
In that sense, the “right member” question is really a forecasting question. The more accurately a health plan can identify the members most likely to experience rising utilization and unstable costs, the better positioned it is to influence both.
How earlier identification can reduce avoidable high-cost utilization
Serious-illness costs often become volatile because support starts too late.
By the time a member has repeated ED use, multiple admissions, unmanaged symptoms, or visible deterioration, the plan is no longer simply managing risk. It is responding to risk that has already materialized. At that stage, opportunities for lower-cost intervention may still exist, but some of the avoidable spend has already occurred.
Earlier identification changes that sequence.
Carelon uses predictive models that run monthly and assign risk of clinical deterioration, unplanned hospitalization, and high-intensity utilization. It also uses claims and demographic data, with physician review of model output for some lines of business before referral.
That matters because earlier identification creates the opportunity for earlier intervention. Members can be engaged before crisis-driven utilization becomes the norm. Symptoms can be managed before they trigger an acute event. Care plans can be aligned before treatment decisions become reactive. Caregivers can receive support before uncertainty turns into an ED visit.
From a financial perspective, that sequence can affect not only the level of cost, but the consistency of cost over time.
How palliative care stabilization can reduce claims volatility
A useful way to think about predictability in this context is stabilization.
High-need members become financially volatile when their care is fragmented, symptoms are unmanaged, and support is only activated after something goes wrong. They become more financially predictable when their condition, care plan, and decision-making environment are more stable.
That is why Carelon ties predictability not only to identification, but also to the interventions that follow. Carelon’s proactive symptom management, 24/7 clinical access, advance care planning, and timely transitions are the drivers of more predictable performance. These are all mechanisms for preventing escalation before it turns into a high-cost claim.
For leaders, that is a meaningful distinction. Predictability is not just a reporting outcome. It is the result of a care model that reduces the conditions under which volatile spending occurs.
What claims volatility means for CFOs, actuaries, and analytics leaders
Each of these audiences is affected by the same problem in a slightly different way.
For CFOs, more predictable serious-illness spending can support stronger financial planning, better margin management, and greater confidence in the performance of high-cost populations.
For actuarial leaders, targeted identification can improve the understanding of where cost variability is concentrated and where intervention is most likely to affect both trend and volatility.
For analytics leaders, the value lies in moving beyond retrospective reporting toward prospective action. It is one thing to identify who generated high cost last quarter. It is more valuable to identify who is most likely to generate unstable cost next quarter and give the organization a chance to intervene first.
That is why the identification strategy matters so much. It creates a bridge between data and operational action. Without that bridge, predictability remains largely a modeling exercise. With it, predictability becomes something the plan can actively influence.
A more disciplined strategy for serious-illness cost management
Too often, serious-illness costs are treated as unavoidable simply because the members are clinically complex. But complexity does not eliminate the opportunity for earlier action. It makes targeted action more important.
Carelon’s model suggests a more disciplined approach: identify a narrow, high-impact segment earlier, intervene before utilization escalates, and stabilize care through coordinated, physician-led support. The purpose is not only to reduce cost in the aggregate. It is to reduce the level and volatility of spending among the members most likely to destabilize both.
That is a more useful way to think about serious-illness management from a finance perspective. Instead of asking how to broadly lower spend, health plans can ask a sharper question: which members are most likely to drive unpredictable, high-cost utilization, and how early can we act?
Why predictable serious-illness spend starts before the claim
In serious-illness care, unstable cost usually begins well before the high-cost event appears on a report. It begins when symptoms go unmanaged, when the wrong members are identified too late, when support is unavailable after hours, and when care decisions happen in crisis instead of in context.
That is why predictable spend starts with the right members.
When plans identify high-risk members earlier and support them before their needs escalate, they are not just improving care. They are improving the conditions for more stable financial performance.
To learn more, request a conversation about targeted serious-illness identification for cost predictability. Talk with a Carelon Palliative Care expert.